Clinical Manifestations and Outcomes of COVID-19 in Diabetes Mellitus People, Yazd, Iran-2021

نویسندگان
Mirzaei, Mohsen ID 1
Askari, Maryam ID 2
Sahami, Mohamad Ali ID 3
Minoosepehr, Mozhgan ID 4
Mehrabbeik, Akram ID 5
Namiranian, Nasim ID 6

1 Yazd Cardiovascular Research Centre, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

2 Genetic and Environmental Adventures Research Center, School of Abarkouh Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

3 Yazd Health Network, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

4 Health Department, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

5 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

6 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

doi
10.18502/ijdo.v15i4.14552
چکیده

Objective: Diabetes mellitus is reported to be the third most prevalent comorbidity with COVID-19, after cardio‐cerebrovascular disease and hypertension. Furthermore, diabetes increases the likelihood of admission to the hospital and intensive care unit and death from COVID-19. The aim of the present study was to compare the clinical manifestations and ...

کلیدواژه‌ها
COVID-19, Diabetes, Inpatients, Outcomes